AC

Anbusekar Chitra

Active Director Designated Partner DIN 11019850
DIN 11019850 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Anbusekar Chitra

Data last updated:

Anbusekar Chitra is a Designated Partner at Agast Pharmaceutical Llp (since 2025).

DIN 11019850
Primary Designation Designated Partner
First Appointment 25 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Mar 20252025Active

Board colleagues of Anbusekar Chitra

NameDINCompanyDesignation
Anthonydoss Praveenkumar11019852Agast Pharmaceutical LlpDesignated Partner
Janakisudha11019851Agast Pharmaceutical LlpDesignated Partner
Perumalsamy Sangeetha08613307Agast Pharmaceutical LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Agast Pharmaceutical Llp
Premium access

Shareholding and investment profile for Anbusekar Chitra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anbusekar Chitra

Anbusekar Chitra currently holds 1 directorship: Agast Pharmaceutical Llp (Designated Partner, since 25 Mar 2025).

Anbusekar Chitra was first appointed on 25 Mar 2025 as Designated Partner at Agast Pharmaceutical Llp.

The current boards of Anbusekar Chitra's companies include Anthonydoss Praveenkumar (Agast Pharmaceutical Llp), Janakisudha (Agast Pharmaceutical Llp), Perumalsamy Sangeetha (Agast Pharmaceutical Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available